Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Niclosamide |
Synonyms | |
Therapy Description |
Niclosamide inhibits Wnt signaling, potentially resulting in decreased tumor growth (PMID: 21531761). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Niclosamide | Niclocide | CTNNB1 Inhibitor 27 | Niclosamide inhibits Wnt signaling, potentially resulting in decreased tumor growth (PMID: 21531761). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
APC inact mut | colorectal cancer | sensitive | Niclosamide | Preclinical | Actionable | In a preclinical study, Niclosamide inhibited proliferation of colorectal cancer cells harboring APC mutations in culture (PMID: 21531761). | 21531761 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05188170 | Phase I | Niclosamide | Phase 1 Study of Niclosamide in Pediatric Patients With Relapsed and Refractory AML | Recruiting | USA | 0 |
NCT02532114 | Phase I | Enzalutamide Niclosamide | Niclosamide and Enzalutamide in Treating Patients With Androgen Receptor Splice Variant-Positive, Castration-Resistant, Metastatic Prostate Cancer | Completed | USA | 0 |
NCT02687009 | Phase I | Niclosamide | A Study of Niclosamide in Patients With Resectable Colon Cancer | Terminated | USA | 0 |